self pay glp 1 Lilly's Zepbound price cut could reshape obesity drug market We believe everyone should have

By offering a new strategy for weight management, GLP-1 receptor agonists hold the potential to reduce the prevalence of obesity-related complications

Amino-acid-encoded supramolecular photothermal nanomedicine for enhanced cancer therapy

In a 40-week double blinded, placebo-controlled study, weekly injections of Tirzepatide (15mg) in Type 2 Diabetes Mellitus (T2DM) patients was capable of reducing body weight by an average of 10.1%, over placebo at 40 weeks

Whether customers are managing busy workdays, active schedules, family life or general wellness goals, SynBio tiredness and fatigue supplements offer practical options that fit easily into everyday routines